Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079430
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2004-03-08
Brief Title:
Paclitaxel Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II Stage III or Stage IV Ovarian Epithelial Primary Peritoneal or Fallopian Tube Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brenner Tumor |
| Fallopian Tube Cancer |
| Ovarian Clear Cell Cystadenocarcinoma |
| Ovarian Endometrioid Adenocarcinoma |
| Ovarian Mixed Epithelial Carcinoma |
| Ovarian Mucinous Cystadenocarcinoma |
| Ovarian Serous Cystadenocarcinoma |
| Ovarian Undifferentiated Adenocarcinoma |
| Primary Peritoneal Cavity Cancer |
| Stage II Ovarian Epithelial Cancer |
| Stage III Ovarian Epithelial Cancer |
| Stage IV Ovarian Epithelial Cancer |
Keywords: